680 filings
Page 24 of 34
6-K
0fk rm5mwa
12 Sep 16
Current report (foreign)
12:00am
6-K
mqbibw
8 Sep 16
RedHill Biopharma Announces Phase Ib/II Study with YELIVA™ Initiated for Multiple Myeloma at a Leading U.S. Academic Medical Center
12:00am
6-K
10aw bdtgi1fxedwrfm6
1 Sep 16
RedHill Biopharma to Present at the 9th Annual BioPharm America International Partnering Conference
12:00am
6-K
9vxp9qwj
31 Aug 16
RedHill Biopharma to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
12:00am
6-K
f8a67pq0w0a52nu
29 Aug 16
RedHill Biopharma Announces Approval of a European Patent Supporting RHB-104 for Multiple Sclerosis
12:00am
6-K
bqjmwr7auozy6wd8i
11 Aug 16
RedHill Biopharma Provides 2016 Semi-Annual R&D Update
12:00am
6-K
ao3c 2hp8sq3a
1 Aug 16
RedHill Biopharma Announces Last Patient Visit in Phase IIa Study with RHB-104 for Multiple Sclerosis
12:00am
6-K
41skpyt59rs 3ff
26 Jul 16
Current report (foreign)
12:00am
6-K
vrm04v9
21 Jul 16
RedHill Biopharma Receives Additional U.S. Patent Covering RHB-105 Ahead of Confirmatory Phase III Study for H. pylori Infection
12:00am
6-K
162ks6z tm1r5zm4g5
19 Jul 16
Current report (foreign)
12:00am
6-K
fpj 06zpj
13 Jul 16
RedHill Biopharma Announces Research Collaboration with NIH for Potential Ebola Treatment
12:00am
6-K
amhpvds1wnowk2008r6
5 Jul 16
Current report (foreign)
12:00am
6-K
la2hf2ugji2y1f
22 Jun 16
RedHill Biopharma Announces Publication Demonstrating Potential Efficacy of RHB-104 for Crohn's Disease Associated with MAP Infection
12:00am
6-K
91sekop61v0
21 Jun 16
RedHill Biopharma Announces Positive Final Results with Primary and Secondary Endpoints Met in Phase 1 Study with YELIVA™ in Advanced Solid Tumors
12:00am
6-K
ppv1t
20 Jun 16
RedHill Biopharma Announces First Patients Dosed in Phase II Study with BEKINDA™ for IBS-D
12:00am
6-K
fi78cfnkhx8b3
15 Jun 16
RedHill Biopharma to Present at JMP Securities Life Sciences Conference
12:00am
6-K
jum a0nqfrnspl7yz
8 Jun 16
Current report (foreign)
12:00am
6-K
kf4kasdyg
31 May 16
RedHill Biopharma to Present at the 2016 BIO International Convention
12:00am
6-K
dm8cdh3751b66k rr
31 May 16
RedHill Biopharma to Present at Jefferies 2016 Healthcare Conference
12:00am
6-K
0z00mibesqbyk
5 May 16
Current report (foreign)
12:00am